Liquid Biopsies – our new study reveals trends, R&D progress, and predicted revenues Where is the liquid biopsy market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead Our 205-page report provides 190 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing liquid biopsy market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, you find revenue forecasts for 4 different segmentations of the market, including forecasts for 3 sample types, 3 biomarker types, 7 applications and 4 end users:
• Liquid biopsy Market Forecasts to 2027, By Sample Type – Blood – Urine – Other
• Liquid biopsy Technologies Market Forecasts to 2027, By Biomarker Type – CTC – ctDNA – Exosomes
• Liquid biopsy Technologies Market Forecasts to 2027, By Application – Lung Cancer – Gastrointestinal Cancer – Breast Cancer – Colorectal Cancer – Leukaemia – Prostate Cancer – Other Cancers
• Liquid biopsy Technologies Market Forecasts to 2027, By End User – Hospitals – Academic Institutes – Diagnostic Laboratories – Cancer Research Centres
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts 5 leading regional markets and 19 leading national markets: • North America – US – Canada • Europe – Germany – France – UK – Italy – Spain – Russia – Rest of Europe • APAC – Japan – China – India – South Korea – Singapore – Australia & New Zealand • Rest of APAC – Latin America – Brazil – Argentina – Rest of Latin America • MEA – GCC – South Africa – Rest of MEA
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Leading companies and the potential for market growth Overall world revenue for liquid biopsy will surpass $0.4bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Liquid biopsy Technologies Market report helps you In summary, our 204-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the world liquid biopsy market and 4 different segmentations, with 3 sample types, 3 biomarker types, 7 applications and 4 end-user types – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for the leading 5 regional and 19 national markets – North America (US, Canada), Latin America (Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), APAC (Japan, China, India, South Korea, Singapore, Australia & New Zealand and Rest of APAC), MEA (GCC, South Africa and Rest of MEA) • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the <enter sector> market and leading companies. You find data, trends and predictions.
Get our report today Global Liquid Biopsy Market Forecast 2017-2027: Analysis of the Liquid Biopsy Market by Sample Type, Biomarker, Application and End User. Avoid missing out – get our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Liquid Biopsy Market Overview 1.2 Liquid Biopsy Imaging Technologies Market Segmentation 1.3 Overview of Findings 1.4 Structure of the Report 1.5 How This Report Delivers 1.6 Key Questions Answered by This Analytical Report 1.7 Who is This Report For? 1.8 Methodology 1.8.1 Primary Research 1.8.2 Secondary Research 1.8.3 Market Evaluation & Forecasting Methodology 1.9 Frequently Asked Questions (FAQ) 1.10 Associated Visiongain Reports 1.11 About Visiongain
2. Liquid Biopsy Market Overview 2.1 History of Liquid Biopsies 2.2 Advantages of Liquid Biopsies 2.3 Trends in Liquid Biopsy Market 2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits 2.3.2 Emergence of Oncogenic Mutations Detection Platforms: 2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures 2.4 Market Dynamics 2.4.1 Drivers 2.4.1.1 Increasing Incidence of Cancer 2.4.1.2 Global Cancer Statistics 2.4.1.3 United States Cancer Statistics 2.4.1.4 United Kingdom Cancer Statistics 2.4.1.5 Lung, Colon, Prostate, and Breast Cancer Statistics 2.4.1.6 Increasing Cancer Prevalence in Asia-Pacific 2.4.1.7 Increasing Rate of Aging Population 2.4.2 Restraints 2.4.2.1 Disparity in Reimbursements 2.4.2.2 Strict Regulatory Environment 2.4.3 Opportunities: 2.4.3.1 Increasing Involvement of Global Market Players Through Collaborations/Agreements: 2.4.3.2 Progress in the Development of Liquid Biopsy Tests: 2.5 Global Liquid Biopsy Market: Revenue Forecast, 2016-2027
3. Global Liquid Biopsy Market, by Sample Type 2017-2027 3.1 Global Liquid Biopsy Market, Blood Sample Segment Revenue Forecast, 2017-2027 3.2 Global Liquid Biopsy Market, By Urine Sample Segment Revenue Forecast, 2017-2027 3.3 Global Liquid Biopsy Market, Others Sample Revenue Forecast, 2017-2027 3.4 Annual growth comparison by Sample Type 3.5 Global Liquid Biopsy Market, By Sample Type Value, AGR (%), CAGR (%) comparison: 2017-2027 3.6 Attractiveness Index and Market Share Analysis by Sample Type
4. Global Liquid Biopsy Market by Biomarker Type 2017-2027 4.1 Global Liquid Biopsy Market by Biomarker Type: Revenue Forecast, 2017-2027 4.2 Global Liquid Biopsy Market, By CTC Biomarker Type Segment Revenue Forecast, 2017-2027 4.3 Global Liquid Biopsy Market, By ctDNA Biomarker Type Segment Revenue Forecast, 2017-2027 4.4 Global Liquid Biopsy Market, By Exosomes Biomarker Type Segment Revenue Forecast, 2017-2027 4.5 AGR (%) comparison by Biomarker Type 4.6 Attractiveness Index and Market Share Analysis by Biomarker Type
5. Global Liquid Biopsy Market by Application 2017-2027 5.1 Global Liquid Biopsy Market by Application: Revenue Forecast, 2017-2027 5.2 Global Liquid Biopsy Market, By Lung Cancer Application Type Segment Revenue Forecast, 2017-2027 5.3 Global Liquid Biopsy Market, By Gastrointestinal Cancer Application Type Segment Revenue Forecast, 2017-2027 5.4 Global Liquid Biopsy Market, By Breast Cancer Application Type Segment Revenue Forecast, 2017-2027 5.5 Global Liquid Biopsy Market, By Colorectal Cancer Application Type Segment Revenue Forecast, 2017-2027 5.6 Global Liquid Biopsy Market, By Leukaemia Cancer Application Type Segment Revenue Forecast, 2017-2027 5.7 Global Liquid Biopsy Market, By Prostate Cancer Application Type Segment Revenue Forecast, 2017-2027 5.8 Global Liquid Biopsy Market, By Other Cancer Application Type Segment Revenue Forecast, 2017-2027 5.9 AGR (%) comparison by Application Type 5.10 Attractiveness Index and Market Share Analysis by Application Type
6. Global Liquid Biopsy Market by End User Type 2017-2027 6.1 Hospitals End User Revenue Forecast, 2017-2027 6.2 Academic Institution End User Revenue Forecast, 2017-2027 6.3 Diagnostic Labs End-User Revenue Forecast, 2017-2027 6.4 Cancer Research Centers End User Revenue Forecast, 2017-2027 6.5 AGR (%) comparison by End User Type 6.6 Attractiveness Index and Market Share Analysis by End User Type
7. The Leading National Markets 2017-2027 7.1 Geographical Breakdown of the Global Liquid Biopsy Market, 2016-2026 7.1.1 AGR (%) and Market Share Analysis by Regions: 2017-2027 7.1.2 Attractiveness Index and Market Share Analysis by Regions: 2017-2027 7.2 North America Liquid Biopsy Market Forecast 2017-2027 7.2.1 U.S. Liquid Biopsy Market Forecast 2017-2027 7.2.2 Canada Liquid Biopsy Market Forecast 2017-2027 7.2.3 AGR (%) and Market Share Analysis for U.S. and Canada: 2017-2027 7.2.4 Attractiveness Index and Market Share Analysis by Regions: 2017-2027 7.3 European Liquid Biopsy Market Forecast 2017-2027 7.3.1 EU5 Liquid Biopsy Market Forecast 2017-2027 7.3.1.1 Germany Liquid Biopsy Market Forecast 2017-2027 7.3.1.2 U.K. Liquid Biopsy Market Forecast 2017-2027 7.3.1.3 Spain Liquid Biopsy Market Forecast 2017-2027 7.3.1.4 France Liquid Biopsy Market Forecast 2017-2027 7.3.1.5 Italy Liquid Biopsy Market Forecast 2017-2027 7.3.2 AGR (%) and Market Share Analysis for EU5 Countries, Russia & Rest of Europe: 2017-2027 7.3.3 Russia Liquid Biopsy Market Forecast 2017-2027 7.3.4 Rest of Europe Liquid Biopsy Market Forecast 2017-2027 7.4 Latin America Liquid Biopsy Market 2017-2027 7.4.1 Brazil Liquid Biopsy Market Forecast 2017-2027 7.4.2 Argentina Liquid Biopsy Market Forecast 2017-2027 7.4.3 Rest of Latin America Liquid Biopsy Market Forecast 2017-2027 7.4.4 AGR (%) and Market Share Analysis for Latin America Countries: 2017-2027 7.4.5 Attractiveness Index for Latin America Countries: 2017-2027 7.5 APAC Liquid Biopsy Market Forecast 2017-2027 7.5.1 Japan Liquid Biopsy Market Forecast 2017-2027 7.5.2 China Biopsy Market Forecast 2017-2027 7.5.3 India Liquid Biopsy Market Forecast 2017-2027 7.5.4 South Korea Biopsy Market Forecast 2017-2027 7.5.5 Singapore Liquid Biopsy Market Forecast 2017-2027 7.5.6 Australia & New Zealand Biopsy Market Forecast 2017-2027 7.5.7 Rest of APAC Liquid Biopsy Market Forecast 2017-2027 7.5.8 AGR (%) and Market Share Analysis for Asia-Pacific Countries: 2017-2027 7.5.9 Attractiveness Index Analysis for Asia-Pacific Countries: 2017-2027 7.6 MEA Liquid Biopsy Market Forecast 2017-202 7.6.1 GCC Liquid Biopsy Market Value in m $, AGR (%) (2016-2027) 7.6.2 South Africa Liquid Biopsy Market Value in m $, AGR (%) (2016-2027) 7.6.3 Rest of MEA Liquid Biopsy Market Value in $m, AGR (%) (2016-2027) 7.6.4 AGR (%) and Market Share Analysis for MEA Countries: 2017-2027 7.6.5 Attractiveness Index for MEA Countries: 2017-2027
9. Qualitative Analysis of the Liquid Biopsy Market 9.1 PESTEL Analysis of the Liquid Biopsy Market 9.1.1 Political 9.1.1.1 Regulatory Bodies: 9.1.1.2 Insurance / Reimbursement: 9.1.2 Economic 9.1.3 Social 9.1.4 Environmental Factors 9.1.5 Technological 9.1.5.1 Decline in use of Old Technologies and Advent of New Technologies 9.1.5.2 Early Stage Diagnosis of Cancer with Liquid Biopsies 9.1.5.3 Improved Liquid Biopsy Techniques 9.1.5.4 Comparison with Tissue Sampling 9.1.5.5 Cost Reductions and Time Saving with Liquid Biopsies 9.1.6 Legal 9.1.6.1 Regulatory Science Challenge 9.1.6.2 FDA 9.1.6.3 Lawsuits and Litigations 9.2 Porter’s Five Forces Analysis 9.2.1 Threat of Substitutes 9.2.2 Bargaining Power of Buyers 9.2.3 Bargaining Power of Suppliers 9.2.4 Threat of New Entrants 9.2.5 Competetive Rivalry
Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B
List of Figures Figure 1.1 Liquid Biopsy Market Segmentation Figure 2.1 Ageing Population Estimates 2010 - 2050 Figure 2.2: Global Liquid Biopsy Market, Revenue ($m) and AGR (%) 2016-2027 Figure 3.1: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m) and AGR (%) 2016-2027 Figure 3.2: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m) and AGR (%) 2016-2027 Figure 3.3: Global Liquid Biopsy Market, Other Sample Segment Revenue ($m) and AGR (%), 2016-2027 Figure 3.4: Global Liquid Biopsy Market AGR (%) analysis by Sample Type: 2016-2027 Figure 3.5: Attractiveness Index and Market Share Analysis by Sample Type 2016-2027 Figure 4.1: Global Liquid Biopsy Market, By CTC Biomarker Type Segment Value in $m and AGR (%) (2016-2027) Figure 4.2: Global Liquid Biopsy Market, By Ctdna Biomarker Type Segment Value in $m and AGR (%) (2016-2027) Figure 4.3: Global Liquid Biopsy Market, By Exosomes Biomarker Type Segment Value in $m and AGR (%) (2016-2027) Figure 4.4: Global Liquid Biopsy Market AGR (%) analysis by Sample Type: 2016-2027 Figure 4.5: Global Liquid Biopsy Market Attractiveness, by Sample Type: 2016-2027 Figure 5.1: Global Lung Cancer Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.2: Global GI Cancer Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.3: Global Breast Cancer Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.4: Global Colorectal Cancer Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.5: Global Leukaemia Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.6: Global Prostate Cancer Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.7: Global Other Cancers Liquid Biopsy Market Forecast: Revenue ($m) and AGR (%) 2016-2027 Figure 5.8: AGR (%) Comparison by Application Type 2016-2027 Figure 5.9: Global Liquid Biopsy Market Forecast: Market Attractiveness by Application Type Figure 6.1: Global Liquid Biopsy Market, By Hospitals End User Type Segment Value in $m and AGR (%) (2016-2027) Figure 6.2: Global Liquid Biopsy Market, By Academic Institution End User Type Segment Value in $m and AGR (%) (2016-2027) Figure 6.3: Global Liquid Biopsy Market, By Diagnostic Labs End User Type Segment Value in $m and AGR (%) (2016-2027) Figure 6.4: Global Liquid Biopsy Market, By Cancer Research Centers End User Type Segment Value in $m and AGR (%) (2016-2027) Figure 6.5: Global Liquid Biopsy Market, by End User Type Segment AGR (%) comparison 2016-2027 Figure 6.6: Global Liquid Biopsy Market, By Cancer Research Centres End User Type Segment Value in $m and AGR (%) (2016-2027) Figure 7.1: Global Liquid Biopsy Market AGR (%) analysis by Region: 2016-2027 Figure 7.2: Global Liquid Biopsy Market Attractiveness Analysis by Region: 2016-2027 Figure 7.3: North America Liquid Biopsy Market Value in US Mn $, AGR (%) (2016-2027) Figure 7.4:North America Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.5: U.S. Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.6: U.S. Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.7: Canada Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.8: Canada Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.9: North America Global Liquid Biopsy Market, AGR (%) Analysis for U.S. and Canada: 2017-2027 Figure 7.10: North America Liquid Biopsy Market AGR (%) analysis by Region: 2016-2027 Figure 7.11: Europe Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.12: Europe Liquid Biopsy Market Absolute $ Opportunity value in Mn $, (2016-2027) Figure 7.13: Germany Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.14: Germany Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.15: U.K. Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.16: U.K. Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.17: Spain Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.18: Spain Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.19: France Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.20: France Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.21: Italy Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.22: Italy Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.23: Europe Liquid Biopsy Market , AGR (%) Comparison by country, 2016-2027 Figure 7.24: Europe Liquid Biopsy Market, Market Attractiveness index, by Countr7.24 2016-2027 Figure 7.25: Russia Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.26: Russia Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.27: Rest of Europe Liquid Biopsy Market Value in $m and AGR (%) (2016-2027) Figure 7.28: Rest of Europe Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.29: Latin America Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.30: Latin America Liquid Biopsy Market Absolute $ Opportunity value in Mn $, (2016-2027) Figure 7.31: Brazil Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.32: Brazil Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.33: Argentina Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.34 Argentina Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.35: Rest of Latin America Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.36: Rest of Latin America Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.37: Rest of Latin America Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.38: Latin America Liquid Biopsy Market, Market Attractiveness Index by country, 2016-2027 Figure 7.39: APAC Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.40: APAC Liquid Biopsy Market Absolute $ Opportunity value in Mn $, (2016-2027) Figure 7.41: Japan Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.42: Japan Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.43: China Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.44: China Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.45: India Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.46: India Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.47: South Korea Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.48: South Korea Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.49: Singapore Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.50: Singapore Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.51: Australia & New Zealand Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.52: Australia & New Zealand Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.53: Rest of APAC Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.54: Rest of APAC Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.55: APAC Liquid Biopsy Market, AGR (%) Analysis, By Country, 2016-2027 Figure 7.56: APAC Liquid Biopsy Market, Attractiveness Index, By Country, 2016-2027 Figure 7.57: MEA Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.58: MEA Liquid Biopsy Market Absolute $ Opportunity value in Mn (2016-2027) Figure 7.59: GCC Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.60: GCC Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.61: S.Africa Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.62: S.Africa Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.63: Rest of MEA Liquid Biopsy Market Value in Mn $, AGR (%) (2016-2027) Figure 7.64: Rest of MEA Liquid Biopsy Market Absolute $ Opportunity value in US Mn $, (2016-2027) Figure 7.65: MEA Liquid Biopsy Market, AGR (%) Analysis by country, 2016-2027 Figure 7.66: MEA Liquid Biopsy Market, Attractiveness Index, By Country, 2016-2027
List of Tables Table 1.1 Global Liquid Biopsy Market Forecast Segmented by Sample Type Revenue ($m), AGR (%) and CAGR (%), 2016-2027 (redacted data) Table 2.1: Global Liquid Biopsy Market, Revenue ($m) and AGR (%) 2016-2027 Table 3.1: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 3.2: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 3.3: Global Liquid Biopsy Market, Other Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 3.4: Global Liquid Biopsy Market Forecast, By Sample Type, Revenue ($m), AGR (%), CAGR (%) 2016-2027 Table 4.1: Global Liquid Biopsy Market Forecast by Biomarker Type - Revenue ($m), AGR (%) and CAGR (%) Table 4.2: Global Liquid Biopsy Market Forecast by Biomarker Type - Revenue ($m), AGR (%) and CAGR (%) Table 4.3: Global Liquid Biopsy Market Forecast by Biomarker Type - Revenue ($m), AGR (%) and CAGR (%) Table 4.4: Global Liquid Biopsy Market Forecast by Biomarker Type - Revenue ($m), AGR (%) and CAGR (%) Table 5.1: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 5.2: Global Lung Cancer Liquid Biopsy Market Forecast: Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 5.3: Global GI Cancer Liquid Biopsy Market Forecast: Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 5.4: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 5.5: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 5.6: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 5.7: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 5.8: Global Liquid Biopsy Market Forecast 2016-2027 ($m, AGR %, CAGR %) Table 6.1: Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 6.2: Hospital Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 6.3: Academic Institution Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 6.4: Diagnostic Laboratory Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 6.5: Cancer Research Centre Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.1: Liquid Biopsy Market, By Geography, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.2: North American Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.3: North American Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.4: North American Liquid Biopsy Market, By Application, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.5: North American Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.6: US Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.7: Canada Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.8: European Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.9: European Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.10 European Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.11: European Liquid Biopsy Market, By Application, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.12: European Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.13: German Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.14: UK Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.15: Spanish Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.16: France Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.17: Italy Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.18: Russia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.19: Rest of Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.20: Latin American Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.21: Latin American Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.22: Latin American Liquid Biopsy Market, By Application, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.23: Latin American Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.24: Brazil Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.25: Argentina Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.26: Rest of Latin America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.27: APAC Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.28: APAC Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.29: APAC Liquid Biopsy Market, By Application, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.30: APAC Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.31: Japan Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.32: China Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.33: Indian Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.34: South Korea Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.35: Singapore Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.36: Australia & New Zealand Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.37 Rest of APAC Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.38: MEA Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.39: MEA Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.40: MEA Liquid Biopsy Market, By Application, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.41: MEA Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.42: GCC Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.43: South African Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 7.44: Rest of MEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2016-2027 Table 8.1: Silicon Biosystems – Major Liquid Biopsy Products Table 8.2: Silicon Biosystems – Recent Developments Table 8.3: MDx Health S.A. Financials, Values in $m, 2014-2015 Table 8.4: MDx Health S.A. Major Liquid Biopsy Products Table 8.5: MDx Health S.A. Recent Developments Table 8.5: MDx Health S.A. Recent Developments (continued) Table 8.5: MDx Health S.A. Recent Developments (continued) Table 8.5: MDx Health S.A. Recent Developments (continued) Table 8.5: MDx Health S.A. Recent Developments (continued) Table 8.6: Biocept Financials ($m) 2014-2015 Table 8.7: Biocept Major Products 2016 Table 8.8: Biocept Recent Developments Table 8.9: Trovagene, Inc. Major Products 2016 Table 8.10: Trovagene, Inc. Financials $’000, 2014-2015 Table 8.11: Trovagene, Inc. Recent Developments Table 8.11: Trovagene, Inc. Recent Developments (continued) Table 8.11: Trovagene, Inc. Recent Developments (continued) Table 8.12: Sysmex Inostics GmbH Major Products 2016 Table 8.13: Sysmex Inostics GmbH Financials 2014-2015 Table 8.14: Sysmex Inostics GmbH Recent Developments Table 8.14: Sysmex Inostics GmbH Recent Developments Table 8.14: Sysmex Inostics GmbH Recent Developments (continued) Table 8.14: Sysmex Inostics GmbH Recent Developments (continued) Table 8.14: Sysmex Inostics GmbH Recent Developments (continued) Table 8.15: Roche Holding AG Financials 2014-2015 Table 8.16: Roche Holding AG Major Liquid Biopsy Products Table 8.17: Roche Holding AG Recent Developments Table 8.18: Pathway Genomics Major Products 2016 Table 8.19: Pathway Genomics Recent Developments
American Pathology Partners Inc Bayer HealthCare AG (Germany) Biocept Cerba Healthcare Clearbridge BioMedics (Singapore) German Partec GmbH G-TAC Co., Ltd. (Japan) HistoGeneX N.V Janseen Global Services LLC LabCorp (U.S.) M3, Inc. (U.S.). MDxHealth SA Menarini Group Merck KGaA Merck Serono (Switzerland) Miraca Life Sciences NovioGendix Holding B.V Pathway Genomics Corporation Prime Health Services, Inc. Roche Holding AG Silicon Biosystems S.p.A South Genetics Inc Swift Biosciences Sysmex Inostics GmbH Trovagene
Organisations Mentioned in This Report Centre for Medicare and Medicaid Services (CMS) Dana-Farber Cancer Institute (U.S.) European Databank on Medical Devices (EUDAMED) Japanese Ministry of Health Labour and Welfare (MHLW) Japanese Pharmaceuticals and Medical Devices Agency (PMDA) Ministry of Health (China) National Health Laboratory of Myanmar National Institute of Statistics and Economic Studies UK National Health Service (NHS) United Nations (UN) University of California (U.S.) University of Michigan Comprehensive Cancer University of Michigan Comprehensive Cancer Center University of Southern California (U.S.) US Food and Drug Administration (FDA) US Oncology Research USC Norris Comprehensive Cancer Center World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast 2017-2027
Download sample pages
Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
